▶ 調査レポート

遠心式血液ポンプのグローバル市場(2023年-2033年):電子式、機械式

• 英文タイトル:Centrifugal Blood Pumps Market by Type (Electronic and Mechanical), by End-Use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and other end-uses), and by Region - 2023 to 2033

Transparency Market Researchが調査・発行した産業分析レポートです。遠心式血液ポンプのグローバル市場(2023年-2033年):電子式、機械式 / Centrifugal Blood Pumps Market by Type (Electronic and Mechanical), by End-Use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and other end-uses), and by Region - 2023 to 2033 / MRC2304D082資料のイメージです。• レポートコード:MRC2304D082
• 出版社/出版日:Transparency Market Research / 2023年1月18日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の当調査レポートでは、遠心式血液ポンプの世界市場を分析し、市場実態を明らかにしています。本書は、エグゼクティブサマリー、市場概要、市場リスク&動向分析、市場背景&基礎データポイント、主な成功要因、需要分析&予測、市場規模分析&予測、種類別(電子式、機械式)分析、エンドユーザー別(病院、外来手術センター、専門クリニック、その他)分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、市場構造分析、競争状況などを収録しています。また、Medtronic Plc、Thoratec Corporation、Terumo Corporation、Qura Srl、Braile Biomedica Ltd.、LivaNova, PLC、XENIOS AG、Getinge ABなどの企業情報を掲載しています。
・エグゼクティブサマリー
・市場概要
・市場リスク&動向分析
・市場背景&基礎データポイント
・主な成功要因
・需要分析&予測
・市場規模分析&予測
・世界の遠心式血液ポンプ市場規模:種類別
- 電子式遠心式血液ポンプの市場規模
- 機械式遠心式血液ポンプの市場規模
・世界の遠心式血液ポンプ市場規模:エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- 専門クリニックにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の遠心式血液ポンプ市場規模:地域別
- 北米の遠心式血液ポンプ市場規模
- 中南米の遠心式血液ポンプ市場規模
- ヨーロッパの遠心式血液ポンプ市場規模
- アジア太平洋の遠心式血液ポンプ市場規模
- 中東・アフリカの遠心式血液ポンプ市場規模
・市場構造分析
・競争状況

Centrifugal Blood Pumps Market – Scope of Report
TMR’s report on the global centrifugal blood pumps market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global centrifugal blood pumps market for the period 2017–2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global centrifugal blood pumps market from 2023 to 2033.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the centrifugal blood pumps market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global centrifugal blood pumps market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global centrifugal blood pumps market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global centrifugal blood pumps market.

The report delves into the competitive landscape of the global centrifugal blood pumps market. Key players operating in the global centrifugal blood pumps market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global centrifugal blood pumps market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market centrifugal blood pumps.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Summary of Statistics
    1.3. Key Market Characteristics & Attributes
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
    3.1. Risk Assessment
        3.1.1. COVID-19 Crisis and Impact on Centrifugal Blood Pumps Demand
        3.1.2. COVID-19 Impact Benchmark with Previous Crisis
        3.1.3. Impact on Market Value (US$ Mn)
        3.1.4. Assessment by Key Countries
        3.1.5. Assessment by Key Market Segments
        3.1.6. Action Points and Recommendation for Suppliers
    3.2. Key Trends Impacting the Market
    3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
    4.1. Global Centrifugal Blood Pumps Market (US$ Mn)
    4.2. Centrifugal Blood Pumps Market Opportunity Assessment (US$ Mn)
        4.2.1. Total Available Market
        4.2.2. Serviceable Addressable Market
        4.2.3. Serviceable Obtainable Market
    4.3. Market Scenario Forecast
        4.3.1. Demand in optimistic Scenario
        4.3.2. Demand in Likely Scenario
        4.3.3. Demand in Conservative Scenario
    4.4. Investment Feasibility Analysis
        4.4.1. Investment in Established Markets
            4.4.1.1. In Short Term
            4.4.1.2. In Long Term
        4.4.2. Investment in Emerging Markets
            4.4.2.1. In Short Term
            4.4.2.2. In Long Term
    4.5. Forecast Factors – Relevance & Impact
        4.5.1. Top Companies Historical Growth
        4.5.2. Global Centrifugal Blood Pumps Market Growth
        4.5.3. Centrifugal Blood Pumps Adoption Rate, By Country
    4.6. Market Dynamics
        4.6.1. Market Driving Factors and Impact Assessment
        4.6.2. Prominent Market Challenges and Impact Assessment
        4.6.3. Centrifugal Blood Pumps Market Opportunities
        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
    5.2. Banking on with Segments High Incremental Opportunity
    5.3. Peer Benchmarking
6. Global Centrifugal Blood Pumps Market Demand Analysis 2018-2022 and Forecast, 2023-2033
    6.1. Historical Market Analysis, 2018-2022
    6.2. Current and Future Market Projections, 2023-2033
    6.3. Y-o-Y Growth Trend Analysis
7. Global Centrifugal Blood Pumps Market Value Analysis 2018-2022 and Forecast, 2023-2033
    7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
    7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
        7.2.1. Y-o-Y Growth Trend Analysis
        7.2.2. Absolute $ Opportunity Analysis
8. Global Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033, By Type
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Mn) Analysis By Type, 2018-2022
    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2023-2033
        8.3.1. Electronic
        8.3.2. Mechanical
    8.4. Market Attractiveness Analysis By Type
9. Global Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033, By End-use
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2018-2022
    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2023-2033
        9.3.1. Hospitals
        9.3.2. Ambulatory Surgical Centerw
        9.3.3. Specialty Clinics
        9.3.4. Other End-uses
    9.4. Market Attractiveness Analysis By End-use
10. Global Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033, By Region
    10.1. Introduction
    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022
    10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2023-2033
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. APAC
        10.3.5. Middle East and Africa (MEA)
    10.4. Market Attractiveness Analysis By Region
11. North America Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033
    11.1. Introduction
    11.2. Pricing Analysis
    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
        11.4.1. By Country
            11.4.1.1. U.S.
            11.4.1.2. Canada
            11.4.1.3. Rest of North America
        11.4.2. By Type
        11.4.3. By End-use
    11.5. Market Attractiveness Analysis
        11.5.1. By Country
        11.5.2. By Type
        11.5.3. By End-use
12. Latin America Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033
    12.1. Introduction
    12.2. Pricing Analysis
    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
        12.4.1. By Country
            12.4.1.1. Brazil
            12.4.1.2. Mexico
            12.4.1.3. Rest of Latin America
        12.4.2. By Type
        12.4.3. By End-use
    12.5. Market Attractiveness Analysis
        12.5.1. By Country
        12.5.2. By Type
        12.5.3. By End-use
13. Europe Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033
    13.1. Introduction
    13.2. Pricing Analysis
    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
        13.4.1. By Country
            13.4.1.1. Germany
            13.4.1.2. France
            13.4.1.3. U.K.
            13.4.1.4. Italy
            13.4.1.5. Spain
            13.4.1.6. Netherlands
            13.4.1.7. Rest of Europe
        13.4.2. By Type
        13.4.3. By End-use
    13.5. Market Attractiveness Analysis
        13.5.1. By Country
        13.5.2. By Type
        13.5.3. By End-use
14. APAC Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033
    14.1. Introduction
    14.2. Pricing Analysis
    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
        14.4.1. By Country
            14.4.1.1. China
            14.4.1.2. Japan
            14.4.1.3. South Korea
            14.4.1.4. Rest of APAC
        14.4.2. By Type
        14.4.3. By End-use
    14.5. Market Attractiveness Analysis
        14.5.1. By Country
        14.5.2. By Type
        14.5.3. By End-use
15. Middle East and Africa Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033
    15.1. Introduction
    15.2. Pricing Analysis
    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
        15.4.1. By Country
            15.4.1.1. Saudi Arabia
            15.4.1.2. South Africa
            15.4.1.3. UAE
            15.4.1.4. Rest of Middle East and Africa
        15.4.2. By Type
        15.4.3. By End-use
    15.5. Market Attractiveness Analysis
        15.5.1. By Country
        15.5.2. By Type
        15.5.3. By End-use
16. Key Countries Centrifugal Blood Pumps Market Analysis 2018-2022 and Forecast 2023-2033
    16.1. Introduction
        16.1.1. Market Value Proportion Analysis, By Key Countries
        16.1.2. Global Vs. Country Growth Comparison
    16.2. US Centrifugal Blood Pumps Market Analysis
        16.2.1. Value Proportion Analysis by Market Taxonomy
        16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.2.2.1. By Type
            16.2.2.2. By End-use
    16.3. Canada Centrifugal Blood Pumps Market Analysis
        16.3.1. Value Proportion Analysis by Market Taxonomy
        16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.3.2.1. By Type
            16.3.2.2. By End-use
    16.4. Mexico Centrifugal Blood Pumps Market Analysis
        16.4.1. Value Proportion Analysis by Market Taxonomy
        16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.4.2.1. By Type
            16.4.2.2. By End-use
    16.5. Brazil Centrifugal Blood Pumps Market Analysis
        16.5.1. Value Proportion Analysis by Market Taxonomy
        16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.5.2.1. By Type
            16.5.2.2. By End-use
    16.6. Germany Centrifugal Blood Pumps Market Analysis
        16.6.1. Value Proportion Analysis by Market Taxonomy
        16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.6.2.1. By Type
            16.6.2.2. By End-use
    16.7. France Centrifugal Blood Pumps Market Analysis
        16.7.1. Value Proportion Analysis by Market Taxonomy
        16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.7.2.1. By Type
            16.7.2.2. By End-use
    16.8. Italy Centrifugal Blood Pumps Market Analysis
        16.8.1. Value Proportion Analysis by Market Taxonomy
        16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.8.2.1. By Type
            16.8.2.2. By End-use
    16.9. Spain Centrifugal Blood Pumps Market Analysis
        16.9.1. Value Proportion Analysis by Market Taxonomy
        16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.9.2.1. By Type
            16.9.2.2. By End-use
    16.10. UK Centrifugal Blood Pumps Market Analysis
        16.10.1. Value Proportion Analysis by Market Taxonomy
        16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.10.2.1. By Type
            16.10.2.2. By End-use
    16.11. Netherlands Centrifugal Blood Pumps Market Analysis
        16.11.1. Value Proportion Analysis by Market Taxonomy
        16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.11.2.1. By Type
            16.11.2.2. By End-use
    16.12. China Centrifugal Blood Pumps Market Analysis
        16.12.1. Value Proportion Analysis by Market Taxonomy
        16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.12.2.1. By Type
            16.12.2.2. By End-use
    16.13. Japan Centrifugal Blood Pumps Market Analysis
        16.13.1. Value Proportion Analysis by Market Taxonomy
        16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.13.2.1. By Type
            16.13.2.2. By End-use
    16.14. South Korea Centrifugal Blood Pumps Market Analysis
        16.14.1. Value Proportion Analysis by Market Taxonomy
        16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.14.2.1. By Type
            16.14.2.2. By End-use
    16.15. Saudi Arabia Centrifugal Blood Pumps Market Analysis
        16.15.1. Value Proportion Analysis by Market Taxonomy
        16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.15.2.1. By Type
            16.15.2.2. By End-use
    16.16. South Africa Centrifugal Blood Pumps Market Analysis
        16.16.1. Value Proportion Analysis by Market Taxonomy
        16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.16.2.1. By Type
            16.16.2.2. By End-use
    16.17. UAE Centrifugal Blood Pumps Market Analysis
        16.17.1. Value Proportion Analysis by Market Taxonomy
        16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
            16.17.2.1. By Type
            16.17.2.2. By End-use
        16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
    17.1. Market Analysis by Tier of Companies
    17.2. Market Concentration
    17.3. Market Share Analysis of Top Players
    17.4. Market Presence Analysis
        17.4.1. By Regional footprint of Players
        17.4.2. Product footprint by Players
18. Competition Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Competition Deep Dive
        18.3.1. Medtronic Plc
            18.3.1.1. Overview
            18.3.1.2. Product Portfolio
            18.3.1.3. Sales Footprint
            18.3.1.4. Strategy Overview
        18.3.2. Thoratec Corporation
            18.3.2.1. Overview
            18.3.2.2. Product Portfolio
            18.3.2.3. Sales Footprint
            18.3.2.4. Strategy Overview
        18.3.3. Terumo Corporation
            18.3.3.1. Overview
            18.3.3.2. Product Portfolio
            18.3.3.3. Sales Footprint
            18.3.3.4. Strategy Overview
        18.3.4. Qura Srl
            18.3.4.1. Overview
            18.3.4.2. Product Portfolio
            18.3.4.3. Sales Footprint
            18.3.4.4. Strategy Overview
        18.3.5. Braile Biomedica Ltd.
            18.3.5.1. Overview
            18.3.5.2. Product Portfolio
            18.3.5.3. Sales Footprint
            18.3.5.4. Strategy Overview
        18.3.6. LivaNova, PLC
            18.3.6.1. Overview
            18.3.6.2. Product Portfolio
            18.3.6.3. Sales Footprint
            18.3.6.4. Strategy Overview
        18.3.7. XENIOS AG
            18.3.7.1. Overview
            18.3.7.2. Product Portfolio
            18.3.7.3. Sales Footprint
            18.3.7.4. Strategy Overview
        18.3.8. Getinge AB
            18.3.8.1. Overview
            18.3.8.2. Product Portfolio
            18.3.8.3. Sales Footprint
            18.3.8.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology